Related references
Note: Only part of the references are listed.Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W. van Boxtel et al.
EUROPEAN JOURNAL OF CANCER (2019)
Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance
Bin Xu et al.
HUMAN PATHOLOGY (2019)
First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study
Paul V. Viscuse et al.
FRONTIERS IN ONCOLOGY (2019)
Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma
Hideaki Takahashi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
Eline Boon et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target
Chit Cheng Yeoh et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Tatiana Strava Correa et al.
CASE REPORTS IN ONCOLOGY (2018)
Androgen Receptor Signaling in Salivary Gland Cancer
Martin G. Dalin et al.
CANCERS (2017)
Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis
Richard L. Bakst et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Salivary duct carcinoma: Treatment, outcomes, and patterns of failure
Meredith L. Johnston et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer
Martin G. Dalin et al.
CLINICAL CANCER RESEARCH (2016)
A 20-Year Review of 75 Cases of Salivary Duct Carcinoma
Mark R. Gilbert et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)
Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma Data From the National Cancer Data Base
Arya Amini et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)
Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database
Vijayvel Jayaprakash et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Share Paper
